Drugs / V001-FcRH5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07395479 | Nov 2025 → Dec 2027 expected | cancer | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V001-FcRH5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07395479 ↗ |
| Modality | Cell therapy | “An in vivo CAR-T drug” NCT07395479 ↗ |
| Route | Intravenous | “administered intravenously” NCT07395479 ↗ |